首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷

市場調查報告書

商品編碼

1954096

日本診斷檢測市場規模、佔有率、趨勢及預測（按檢測類型、技術、檢體類型、檢測方法、最終用戶應用和地區分類），2026-2034年

Japan Diagnostic Testing Market Size, Share, Trends and Forecast by Test Type, Technology, Sample Type, Mode of Testing, Application End User, and Region, 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

日本診斷檢測市場規模在2025年達到126億美元。 IMARC Group預測，到2034年，該市場規模將達到192億美元，2026年至2034年的複合年成長率（CAGR）為4.82%。醫療技術的進步、公眾健康意識的提高以及慢性病盛行率的上升，正推動著該市場顯著成長。分子診斷、影像診斷和就地檢驗領域的技術創新正在拓展市場機會。在完善的醫療基礎設施和對早期診斷需求的推動下，預計該市場將進一步發展，並鞏固其在日本診斷檢測市場的佔有率。

日本診斷檢測市場的發展趨勢：

就地檢驗的需求日益成長

在日本，即時檢測（POC）因其能夠快速且方便地在患者所在之處提供診斷結果，正變得越來越普及。它特別適用於急診室、診所和居家醫療機構，在這些場所，快速且準確的結果有助於即時做出決策。日本不斷成長的人口和老化也推動了對即時檢測的需求，因為早期診斷和治療至關重要。即時檢測技術的進步，例如血糖值測量、妊娠檢測和感染疾病檢測，最大限度地縮短了患者和醫護人員的等待時間，並提高了醫療效率。此外，即時檢測的便利性減輕了醫療機構的負擔，並促進了資源的合理利用。例如，2023年6月，希森美康公司宣布推出全球首個可在30分鐘內檢測抗菌藥物敏感性的即時檢測系統。該系統專為尿道感染設計，利用創新的微流體技術提供快速結果，最佳化抗生素的使用，並有助於解決抗菌藥物抗藥性（AMR）這一緊迫的全球性問題。隨著日本致力於改善醫療保健服務並緩解醫院擁擠狀況，預計即時診斷工具市場將迅速擴張，並成為該國醫療保健基礎設施的關鍵組成部分。

人工智慧（AI）整合

人工智慧（AI）正在改變日本的診斷檢測市場，顯著提升了檢測結果解讀的準確性、速度和效率。如今，人工智慧演算法已被整合到診斷設備中，使其能夠比傳統方法更有效地分析複雜數據。這在影像學、病理學和分子診斷等領域尤其重要，因為人工智慧可以快速識別人類臨床醫生可能忽略的模式和異常情況。人工智慧還能減少人為錯誤，確保更可靠的診斷並改善患者預後。例如，2025年1月，Monitor公司與DoctorNet合作，在日本推出了人工智慧肺癌診斷工具「MONCAD CTLN」。該軟體可輔助放射科醫師透過電腦斷層掃描檢測肺癌。鑑於日本放射科醫師短缺，此次合作旨在加強人工智慧輔助診斷在醫療領域的應用。此外，人工智慧驅動的工具還能分析基因數據並提案個人化治療方案，進而協助實現精準醫療。隨著對人工智慧技術投入的不斷增加，日本的醫療保健系統在疾病管理方面正變得更加積極和精準。人工智慧的持續整合有望極大地促進日本診斷測試市場的成長，推動創新並增加對人工智慧驅動的診斷解決方案的需求。

本報告解答的關鍵問題

日本的診斷檢測市場目前表現如何？未來幾年又將如何發展？
日本的診斷檢測市場是如何依檢測類型細分的？
日本診斷檢測市場按技術是如何細分的？
日本診斷檢測市場按檢體類型分類的情況如何？
日本診斷檢測市場依檢測方法分類的組成是怎樣的？
日本診斷檢測市場按應用領域分類的市場區隔如何？
日本診斷檢測市場依最終用戶分類的組成是怎樣的？
日本診斷檢測市場按地區分類的組成是怎樣的？
日本診斷檢測市場價值鏈的不同階段有哪些？
日本診斷檢測市場的主要促進因素和挑戰是什麼？
日本診斷檢測市場的結構是怎麼樣的？主要參與者有哪些？
日本診斷檢測市場的競爭程度如何？

The Japan diagnostic testing market size reached USD 12.6 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 19.2 Billion by 2034 , exhibiting a growth rate (CAGR) of 4.82 % during 2026-2034 . The market is witnessing significant growth driven by advances in medical technologies, increasing healthcare awareness, and rising prevalence of chronic diseases. Innovations in molecular diagnostics, imaging, and point-of-care testing are expanding market opportunities. With a strong healthcare infrastructure and demand for early diagnosis, the market is poised for significant developments, further solidifying Japan diagnostic testing market share.

JAPAN DIAGNOSTIC TESTING MARKET TRENDS:

Growing Demand of Point-of-Care Testing

Point-of-care (POC) testing is increasingly popular in Japan because it offers quicker, more convenient diagnostic results directly at the patient's site. The instruments prove especially useful in emergency rooms, clinics, and home care situations, providing speedy and accurate results that support immediate decision-making. Japan's population growth and increasing aging rate also fuel demand for POC testing, where early diagnosis and treatment are essential. With advances in technologies like instant blood glucose testing, pregnancy tests, and infection detection, the waits for patients and healthcare professionals are minimized and care efficiency increased. Additionally, the convenience offered by POC tests relieves healthcare facilities from the workload, and resource utilization is enhanced. For instance, in June 2023, Sysmex Corporation announced the launch of the world's first point-of-care testing system that detects antimicrobial susceptibility within 30 minutes. Designed for urinary tract infections, the system utilizes innovative microfluidic technology to provide rapid results, enhancing antimicrobial use and addressing the urgent global threat of antimicrobial resistance (AMR). As Japan focuses on improving healthcare accessibility and reducing hospital overcrowding, the POC diagnostic tools market is expected to expand rapidly, becoming a key part of the nation's healthcare infrastructure.

Integration of Artificial Intelligence

Artificial Intelligence (AI) is transforming the Japan diagnostic testing market by enhancing accuracy, speed, and efficiency in test result interpretation. AI algorithms are now being integrated into diagnostic devices, enabling them to analyze complex data more effectively than traditional methods. This is particularly beneficial in areas such as imaging, pathology, and molecular diagnostics, where AI can quickly identify patterns and anomalies that may be overlooked by human clinicians. AI also reduces the chances of human error, ensuring more reliable diagnoses and improving patient outcomes. For instance, in January 2025, Monitor Corporation announced the launch of its AI lung cancer diagnosis tool, MONCAD CTLN, in Japan through a partnership with Doctor-NET. The software aids radiologists in detecting lung cancer via CT scans. With Japan's radiologist shortage, this collaboration aims to enhance AI-assisted diagnostics in the healthcare sector. Moreover, AI-driven tools assist in personalized medicine by analyzing genetic data to recommend tailored treatment plans. With growing investment in AI technologies, Japan's healthcare system is becoming more proactive and precise in managing diseases. The continued integration of AI is expected to contribute significantly to the Japan diagnostic testing market growth, driving innovation and increasing demand for AI-powered diagnostic solutions.

JAPAN DIAGNOSTIC TESTING MARKET SEGMENTATION:

Test Type Insights:

Laboratory Testing
Point-of-Care Testing (POCT)
Imaging Diagnostics
Molecular Diagnostics
Others

Technology Insights:

Immunoassay-Based
PCR-Based
Next Gen Sequencing
Spectroscopy-Based
Chromatography-Based
Microfluidics

Sample Type Insights:

Blood
Urine
Saliva
Sweat
Hair

Mode of Testing Insights:

Prescription Based Testing
OTC Testing

Application Insights:

Oncology
Cardiology
Orthopedics
Gastroenterology
Gynecology
Neurology
Odontology

End User Insights:

Hospitals
Diagnostic Centers
Ambulatory Surgical Centers (ASCs)
Specialty Clinics
Homecare
Blood Banks
Research Labs and Institutes

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan diagnostic testing market performed so far and how will it perform in the coming years?
What is the breakup of the Japan diagnostic testing market on the basis of test type?
What is the breakup of the Japan diagnostic testing market on the basis of technology?
What is the breakup of the Japan diagnostic testing market on the basis of sample type?
What is the breakup of the Japan diagnostic testing market on the basis of mode of testing?
What is the breakup of the Japan diagnostic testing market on the basis of application?
What is the breakup of the Japan diagnostic testing market on the basis of end user?
What is the breakup of the Japan diagnostic testing market on the basis of region?
What are the various stages in the value chain of the Japan diagnostic testing market?
What are the key driving factors and challenges in the Japan diagnostic testing market?
What is the structure of the Japan diagnostic testing market and who are the key players?
What is the degree of competition in the Japan diagnostic testing market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Diagnostic Testing Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Diagnostic Testing Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Diagnostic Testing Market - Breakup by Test Type

6.1 Laboratory Testing
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Point-of-Care Testing (POCT)
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Imaging Diagnostics
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Molecular Diagnostics
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2020-2025)
- 6.5.2 Market Forecast (2026-2034)

7 Japan Diagnostic Testing Market - Breakup by Technology

7.1 Immunoassay-Based
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 PCR-Based
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Next Gen Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Spectroscopy-Based
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Chromatography-Based
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)
7.6 Microfluidics
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2020-2025)
- 7.6.3 Market Forecast (2026-2034)
7.7 Others
- 7.7.1 Historical and Current Market Trends (2020-2025)
- 7.7.2 Market Forecast (2026-2034)

8 Japan Diagnostic Testing Market - Breakup by Sample Type

8.1 Blood
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Urine
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Saliva
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)
8.4 Sweat
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Forecast (2026-2034)
8.5 Hair
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Forecast (2026-2034)
8.6 Others
- 8.6.1 Historical and Current Market Trends (2020-2025)
- 8.6.2 Market Forecast (2026-2034)

9 Japan Diagnostic Testing Market - Breakup by Mode of Testing

9.1 Prescription Based Testing
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 OTC Testing
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)

10 Japan Diagnostic Testing Market - Breakup by Application

10.1 Oncology
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Cardiology
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)
10.3 Orthopedics
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Forecast (2026-2034)
10.4 Gastroenterology
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Forecast (2026-2034)
10.5 Gynecology
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Forecast (2026-2034)
10.6 Neurology
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Forecast (2026-2034)
10.7 Odontology
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Forecast (2026-2034)
10.8 Others
- 10.8.1 Historical and Current Market Trends (2020-2025)
- 10.8.2 Market Forecast (2026-2034)

11 Japan Diagnostic Testing Market - Breakup by End User

11.1 Hospitals
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Forecast (2026-2034)
11.2 Diagnostic Center
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Forecast (2026-2034)
11.3 Ambulatory Surgical Centers (ASCs)
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2020-2025)
- 11.3.3 Market Forecast (2026-2034)
11.4 Specialty Clinics
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2020-2025)
- 11.4.3 Market Forecast (2026-2034)
11.5 Homecare
- 11.5.1 Overview
- 11.5.2 Historical and Current Market Trends (2020-2025)
- 11.5.3 Market Forecast (2026-2034)
11.6 Blood Banks
- 11.6.1 Overview
- 11.6.2 Historical and Current Market Trends (2020-2025)
- 11.6.3 Market Forecast (2026-2034)
11.7 Research Labs and Institutes
- 11.7.1 Overview
- 11.7.2 Historical and Current Market Trends (2020-2025)
- 11.7.3 Market Forecast (2026-2034)
11.8 Others
- 11.8.1 Historical and Current Market Trends (2020-2025)
- 11.8.2 Market Forecast (2026-2034)

12 Japan Diagnostic Testing Market - Breakup by Region

12.1 Kanto Region
- 12.1.1 Overview
- 12.1.2 Historical and Current Market Trends (2020-2025)
- 12.1.3 Market Breakup by Test Type
- 12.1.4 Market Breakup by Technology
- 12.1.5 Market Breakup by Sample Type
- 12.1.6 Market Breakup by Mode of Testing
- 12.1.7 Market Breakup by Application
- 12.1.8 Market Breakup by End User
- 12.1.9 Key Players
- 12.1.10 Market Forecast (2026-2034)
12.2 Kansai/Kinki Region
- 12.2.1 Overview
- 12.2.2 Historical and Current Market Trends (2020-2025)
- 12.2.3 Market Breakup by Test Type
- 12.2.4 Market Breakup by Technology
- 12.2.5 Market Breakup by Sample Type
- 12.2.6 Market Breakup by Mode of Testing
- 12.2.7 Market Breakup by Application
- 12.2.8 Market Breakup by End User
- 12.2.9 Key Players
- 12.2.10 Market Forecast (2026-2034)
12.3 Central/ Chubu Region
- 12.3.1 Overview
- 12.3.2 Historical and Current Market Trends (2020-2025)
- 12.3.3 Market Breakup by Test Type
- 12.3.4 Market Breakup by Technology
- 12.3.5 Market Breakup by Sample Type
- 12.3.6 Market Breakup by Mode of Testing
- 12.3.7 Market Breakup by Application
- 12.3.8 Market Breakup by End User
- 12.3.9 Key Players
- 12.3.10 Market Forecast (2026-2034)
12.4 Kyushu-Okinawa Region
- 12.4.1 Overview
- 12.4.2 Historical and Current Market Trends (2020-2025)
- 12.4.3 Market Breakup by Test Type
- 12.4.4 Market Breakup by Technology
- 12.4.5 Market Breakup by Sample Type
- 12.4.6 Market Breakup by Mode of Testing
- 12.4.7 Market Breakup by Application
- 12.4.8 Market Breakup by End User
- 12.4.9 Key Players
- 12.4.10 Market Forecast (2026-2034)
12.5 Tohoku Region
- 12.5.1 Overview
- 12.5.2 Historical and Current Market Trends (2020-2025)
- 12.5.3 Market Breakup by Test Type
- 12.5.4 Market Breakup by Technology
- 12.5.5 Market Breakup by Sample Type
- 12.5.6 Market Breakup by Mode of Testing
- 12.5.7 Market Breakup by Application
- 12.5.8 Market Breakup by End User
- 12.5.9 Key Players
- 12.5.10 Market Forecast (2026-2034)
12.6 Chugoku Region
- 12.6.1 Overview
- 12.6.2 Historical and Current Market Trends (2020-2025)
- 12.6.3 Market Breakup by Test Type
- 12.6.4 Market Breakup by Technology
- 12.6.5 Market Breakup by Sample Type
- 12.6.6 Market Breakup by Mode of Testing
- 12.6.7 Market Breakup by Application
- 12.6.8 Market Breakup by End User
- 12.6.9 Key Players
- 12.6.10 Market Forecast (2026-2034)
12.7 Hokkaido Region
- 12.7.1 Overview
- 12.7.2 Historical and Current Market Trends (2020-2025)
- 12.7.3 Market Breakup by Test Type
- 12.7.4 Market Breakup by Technology
- 12.7.5 Market Breakup by Sample Type
- 12.7.6 Market Breakup by Mode of Testing
- 12.7.7 Market Breakup by Application
- 12.7.8 Market Breakup by End User
- 12.7.9 Key Players
- 12.7.10 Market Forecast (2026-2034)
12.8 Shikoku Region
- 12.8.1 Overview
- 12.8.2 Historical and Current Market Trends (2020-2025)
- 12.8.3 Market Breakup by Test Type
- 12.8.4 Market Breakup by Technology
- 12.8.5 Market Breakup by Sample Type
- 12.8.6 Market Breakup by Mode of Testing
- 12.8.7 Market Breakup by Application
- 12.8.8 Market Breakup by End User
- 12.8.9 Key Players
- 12.8.10 Market Forecast (2026-2034)

13 Japan Diagnostic Testing Market - Competitive Landscape

13.1 Overview
13.2 Market Structure
13.3 Market Player Positioning
13.4 Top Winning Strategies
13.5 Competitive Dashboard
13.6 Company Evaluation Quadrant

14 Profiles of Key Players

14.1 Company A
- 14.1.1 Business Overview
- 14.1.2 Services Offered
- 14.1.3 Business Strategies
- 14.1.4 SWOT Analysis
- 14.1.5 Major News and Events
14.2 Company B
- 14.2.1 Business Overview
- 14.2.2 Services Offered
- 14.2.3 Business Strategies
- 14.2.4 SWOT Analysis
- 14.2.5 Major News and Events
14.3 Company C
- 14.3.1 Business Overview
- 14.3.2 Services Offered
- 14.3.3 Business Strategies
- 14.3.4 SWOT Analysis
- 14.3.5 Major News and Events
14.4 Company D
- 14.4.1 Business Overview
- 14.4.2 Services Offered
- 14.4.3 Business Strategies
- 14.4.4 SWOT Analysis
- 14.4.5 Major News and Events
14.5 Company E
- 14.5.1 Business Overview
- 14.5.2 Services Offered
- 14.5.3 Business Strategies
- 14.5.4 SWOT Analysis
- 14.5.5 Major News and Events

15 Japan Diagnostic Testing Market - Industry Analysis

15.1 Drivers, Restraints, and Opportunities
- 15.1.1 Overview
- 15.1.2 Drivers
- 15.1.3 Restraints
- 15.1.4 Opportunities
15.2 Porters Five Forces Analysis
- 15.2.1 Overview
- 15.2.2 Bargaining Power of Buyers
- 15.2.3 Bargaining Power of Suppliers
- 15.2.4 Degree of Competition
- 15.2.5 Threat of New Entrants
- 15.2.6 Threat of Substitutes
15.3 Value Chain Analysis